Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Novel quinolone-based potent and selective HDAC6 inhibitors: synthesis, molecular modeling studies and biological investigation

Title: Novel quinolone-based potent and selective HDAC6 inhibitors: synthesis, molecular modeling studies and biological investigation
Authors: Relitti N.; Saraswati A. P.; Chemi G.; Brindisi M.; Brogi S.; Herp D.; Schmidtkunz K.; Saccoccia F.; Ruberti G.; Ulivieri C.; Vanni F.; Sarno F.; Altucci L.; Lamponi S.; Jung M.; Gemma S.; Butini S.; Campiani G.
Contributors: Relitti, N.; Saraswati, A. P.; Chemi, G.; Brindisi, M.; Brogi, S.; Herp, D.; Schmidtkunz, K.; Saccoccia, F.; Ruberti, G.; Ulivieri, C.; Vanni, F.; Sarno, F.; Altucci, L.; Lamponi, S.; Jung, M.; Gemma, S.; Butini, S.; Campiani, G.
Publication Year: 2021
Collection: Università degli Studi di Siena: USiena air
Subject Terms: Cancer; HDAC; HDAC6 inhibitor; Molecular modeling; Quinolone synthesi; Structure-activity relationships
Description: In this work we describe the synthesis of potent and selective quinolone-based histone deacetylase 6 (HDAC6) inhibitors. The quinolone moiety has been exploited as an innovative bioactive cap-group for HDAC6 inhibition; its synthesis was achieved by applying a multicomponent reaction. The optimization of potency and selectivity of these products was performed by employing computational studies which led to the discovery of the diethylaminomethyl derivatives 7g and 7k as the most promising hit molecules. These compounds were investigated in cellular studies to evaluate their anticancer effect against colon (HCT-116) and histiocytic lymphoma (U9347) cancer cells, showing good to excellent potency, leading to tumor cell death by apoptosis induction. The small molecules 7a, 7g and 7k were able to strongly inhibit the cytoplasmic and slightly the nuclear HDAC enzymes, increasing the acetylation of tubulin and of the lysine 9 and 14 of histone 3, respectively. Compound 7g was also able to increase Hsp90 acetylation levels in HCT-116 cells, thus further supporting its HDAC6 inhibitory profile. Cytotoxicity and mutagenicity assays of these molecules showed a safe profile; moreover, the HPLC analysis of compound 7k revealed good solubility and stability profile.
Document Type: article in journal/newspaper
File Description: ELETTRONICO
Language: English
Relation: info:eu-repo/semantics/altIdentifier/pmid/33199154; info:eu-repo/semantics/altIdentifier/wos/WOS:000629622800003; volume:212; firstpage:1; lastpage:20; numberofpages:20; journal:EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY; http://hdl.handle.net/11365/1123251; https://www.sciencedirect.com/science/article/pii/S0223523420309703
DOI: 10.1016/j.ejmech.2020.112998
Availability: http://hdl.handle.net/11365/1123251; https://doi.org/10.1016/j.ejmech.2020.112998; https://www.sciencedirect.com/science/article/pii/S0223523420309703
Rights: info:eu-repo/semantics/openAccess
Accession Number: edsbas.3CC5CE8F
Database: BASE